Korean J Med.  2014 Nov;87(5):615-618. 10.3904/kjm.2014.87.5.615.

A Case of Thrombotic Thrombocytopenic Purpura associated with Clopidogrel in a Patient with Acute Cerebral Infarction

Affiliations
  • 1Department of Internal Medicine, The Catholic University of Korea, College of Medicine, Seoul, Korea. junpearl19@catholic.ac.kr

Abstract

Clopidogrel is an antiplatelet agent prescribed widely to prevent stent thrombosis after coronary or peripheral vascular interventions and for stroke prophylaxis. The side effects of this drug include gastrointestinal symptoms, such as nausea, abdominal pain, vomiting, and bleeding. Thrombotic thrombocytopenia purpura (TTP) is a rare complication of this drug. Here, we report a case of clopidogrel-associated TTP in a patient with cerebral infarction. To our knowledge, it is first reported case of clopidogrel-associated TTP in Korea.

Keyword

Thrombotic thrombocytopenic purpura; Clopidogrel

MeSH Terms

Abdominal Pain
Cerebral Infarction*
Hemorrhage
Humans
Korea
Nausea
Purpura
Purpura, Thrombotic Thrombocytopenic*
Stents
Stroke
Thrombocytopenia
Thrombosis
Vomiting
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr